MetalloBio
@metallobioltd.bsky.social
https://www.metallobio.com/about-us/mission-impact
Antimicrobials development company, designing and testing completely new types of antibiotics.
Antimicrobials development company, designing and testing completely new types of antibiotics.
MetalloBio's R&D team has developed a line of new antimicrobial plastics for use in settings where infection control is a high priority consideration. Testing to ISO22196 standards indicates far superior efficacy to currently available products, with an up-to 99.997% reduction in bacterial load.
November 26, 2025 at 10:16 AM
MetalloBio's R&D team has developed a line of new antimicrobial plastics for use in settings where infection control is a high priority consideration. Testing to ISO22196 standards indicates far superior efficacy to currently available products, with an up-to 99.997% reduction in bacterial load.
The sustained efforts of our team have supported a recent slew of granted patents, expanding our intellectual property portfolio.
For the full story:
www.metallobio.com/newsandevent...
For the full story:
www.metallobio.com/newsandevent...
June 5, 2025 at 1:09 PM
The sustained efforts of our team have supported a recent slew of granted patents, expanding our intellectual property portfolio.
For the full story:
www.metallobio.com/newsandevent...
For the full story:
www.metallobio.com/newsandevent...
As a previous recipient of multiple Royal Society Fellowships, Professor Jim Thomas has been recently featured in their publications.
To see full details: royalsociety.org/grants/caree...
To see full details: royalsociety.org/grants/caree...
Career pathway tracker | Royal Society
Results from a major alumni survey of the University Research Fellowship and Dorothy Hodgkin Fellowships.
royalsociety.org
May 9, 2025 at 1:03 PM
As a previous recipient of multiple Royal Society Fellowships, Professor Jim Thomas has been recently featured in their publications.
To see full details: royalsociety.org/grants/caree...
To see full details: royalsociety.org/grants/caree...
MetalloBio is pleased to announce the establishment of their Scientific Advisory Group. When conducting novel research it is imperative to seek the counsel of those with tenure in the field. They shall drive innovation and inform our scientific strategies.
www.metallobio.com/newsandevent...
www.metallobio.com/newsandevent...
Scientific Advisory Group | |
www.metallobio.com
April 10, 2025 at 10:16 AM
MetalloBio is pleased to announce the establishment of their Scientific Advisory Group. When conducting novel research it is imperative to seek the counsel of those with tenure in the field. They shall drive innovation and inform our scientific strategies.
www.metallobio.com/newsandevent...
www.metallobio.com/newsandevent...
MetalloBio shall be represented at Biotrinity by our CEO Michael Murray. Conferences, such as this, are integral to the growth and development of MetalloBio.
obn.glueup.com/event/biotri...
#AMR #Untreatableinfections #GlobalHealth
obn.glueup.com/event/biotri...
#AMR #Untreatableinfections #GlobalHealth
BioTrinity 2025 | OBN (UK) Ltd
BioTrinity is OBN's industry leading life sciences conference, designed to catalyse growth across the industry.
obn.glueup.com
March 29, 2025 at 10:16 AM
MetalloBio shall be represented at Biotrinity by our CEO Michael Murray. Conferences, such as this, are integral to the growth and development of MetalloBio.
obn.glueup.com/event/biotri...
#AMR #Untreatableinfections #GlobalHealth
obn.glueup.com/event/biotri...
#AMR #Untreatableinfections #GlobalHealth
MetalloBio is pleased to announce the appointment of Dr Eddy Littler as Chairman of the Board. Extensive experience will be important in helping to guide MetalloBio’s growth.
www.metallobio.com/newsandevent...
www.metallobio.com/newsandevent...
March 21, 2025 at 11:10 AM
MetalloBio is pleased to announce the appointment of Dr Eddy Littler as Chairman of the Board. Extensive experience will be important in helping to guide MetalloBio’s growth.
www.metallobio.com/newsandevent...
www.metallobio.com/newsandevent...
Over the last year MetalloBio has secured investment and a significant grant from Innovate UK. Our team and peers have conducted studies with promising results, and solving technical challenges has put us in good stead for 2025. In total £700,000 of equity finance was raised, supporting our future.
January 19, 2025 at 3:38 PM
Over the last year MetalloBio has secured investment and a significant grant from Innovate UK. Our team and peers have conducted studies with promising results, and solving technical challenges has put us in good stead for 2025. In total £700,000 of equity finance was raised, supporting our future.
Don't invest unless you're prepared to lose all the money you invest.
#crowdfunding #untreatableinfection #investment #innovation #SuperBugs
europe.republic.com/metallobio?i...
#crowdfunding #untreatableinfection #investment #innovation #SuperBugs
europe.republic.com/metallobio?i...
December 18, 2024 at 12:29 PM
Don't invest unless you're prepared to lose all the money you invest.
#crowdfunding #untreatableinfection #investment #innovation #SuperBugs
europe.republic.com/metallobio?i...
#crowdfunding #untreatableinfection #investment #innovation #SuperBugs
europe.republic.com/metallobio?i...
Don't invest unless you're prepared to lose everything you invest.
Complicated infections are predicted to grow substantially in global market value by 2030. Our #R&D is aimed at overcoming #AMR, this impacts every existing antibiotic. It's a significant market.
europe.republic.com/metallobio/s...
Complicated infections are predicted to grow substantially in global market value by 2030. Our #R&D is aimed at overcoming #AMR, this impacts every existing antibiotic. It's a significant market.
europe.republic.com/metallobio/s...
December 16, 2024 at 5:05 PM
Don't invest unless you're prepared to lose everything you invest.
Complicated infections are predicted to grow substantially in global market value by 2030. Our #R&D is aimed at overcoming #AMR, this impacts every existing antibiotic. It's a significant market.
europe.republic.com/metallobio/s...
Complicated infections are predicted to grow substantially in global market value by 2030. Our #R&D is aimed at overcoming #AMR, this impacts every existing antibiotic. It's a significant market.
europe.republic.com/metallobio/s...
Don’t invest unless you’re prepared to lose all the money you invest.
How do we compete with bigger companies and drive value creation? There are five key strengths that we have as a company that builds our value.
#antibioticresistantinfections
europe.republic.com/metallobio/s...
December 15, 2024 at 12:22 PM
Don’t invest unless you’re prepared to lose all the money you invest.
How do we compete with bigger companies and drive value creation? There are five key strengths that we have as a company that builds our value.
#antibioticresistantinfections
europe.republic.com/metallobio/s...
The #EU has just announced a €40 million p.a. deal with Menarini. To understand how this improves commercial prospects for #antibiotics developers request our Pitch Deck.
ted.europa.eu/en/notice/-/...
ted.europa.eu/en/notice/-/...
741620-2024 - Result
ted.europa.eu
December 14, 2024 at 2:31 PM
The #EU has just announced a €40 million p.a. deal with Menarini. To understand how this improves commercial prospects for #antibiotics developers request our Pitch Deck.
ted.europa.eu/en/notice/-/...
ted.europa.eu/en/notice/-/...
Don't invest unless you're prepared to lose all the money you invest.
In both computer software and #bacterialinfections when an issue arises finding the root cause takes time and work.
We wish to begin treating these issues before they become overwhelming.
europe.republic.com/metallobio/s...
In both computer software and #bacterialinfections when an issue arises finding the root cause takes time and work.
We wish to begin treating these issues before they become overwhelming.
europe.republic.com/metallobio/s...
December 14, 2024 at 11:49 AM
Don't invest unless you're prepared to lose all the money you invest.
In both computer software and #bacterialinfections when an issue arises finding the root cause takes time and work.
We wish to begin treating these issues before they become overwhelming.
europe.republic.com/metallobio/s...
In both computer software and #bacterialinfections when an issue arises finding the root cause takes time and work.
We wish to begin treating these issues before they become overwhelming.
europe.republic.com/metallobio/s...
Don’t invest unless you’re prepared to lose all the money you invest.
MetalloBio has now amassed over 500 investors. Each milestone we hit in funding, pushes our #R&D further which increases the equity value.
Investing helps drive progress forward.
europe.republic.com/metallobio/s...
MetalloBio has now amassed over 500 investors. Each milestone we hit in funding, pushes our #R&D further which increases the equity value.
Investing helps drive progress forward.
europe.republic.com/metallobio/s...
December 12, 2024 at 3:23 PM
Don’t invest unless you’re prepared to lose all the money you invest.
MetalloBio has now amassed over 500 investors. Each milestone we hit in funding, pushes our #R&D further which increases the equity value.
Investing helps drive progress forward.
europe.republic.com/metallobio/s...
MetalloBio has now amassed over 500 investors. Each milestone we hit in funding, pushes our #R&D further which increases the equity value.
Investing helps drive progress forward.
europe.republic.com/metallobio/s...
Don’t invest unless you're prepared to lose all the money you invest.
Our funding drives the pace of our #R&D, but it cannot run forever
After midnight on Wednesday 18th Dec our fundraising closes.
Join us whilst there is still time
europe.republic.com/metallobio?i...
Our funding drives the pace of our #R&D, but it cannot run forever
After midnight on Wednesday 18th Dec our fundraising closes.
Join us whilst there is still time
europe.republic.com/metallobio?i...
Metallobio
When investing, capital is at risk. MetalloBio is an antimicrobials company, designing and testing completely new types of antibiotic drugs.
europe.republic.com
December 11, 2024 at 10:44 PM
Don’t invest unless you're prepared to lose all the money you invest.
Our funding drives the pace of our #R&D, but it cannot run forever
After midnight on Wednesday 18th Dec our fundraising closes.
Join us whilst there is still time
europe.republic.com/metallobio?i...
Our funding drives the pace of our #R&D, but it cannot run forever
After midnight on Wednesday 18th Dec our fundraising closes.
Join us whilst there is still time
europe.republic.com/metallobio?i...
Don't invest unless you're prepared to lose all the money you invest.
Our experienced Finance Director, and incredible research scientists' relentless work have ensured that we use funds cannily to conduct R&D. Invest today to see how much we can accomplish.
europe.republic.com/metallobio?i...
Our experienced Finance Director, and incredible research scientists' relentless work have ensured that we use funds cannily to conduct R&D. Invest today to see how much we can accomplish.
europe.republic.com/metallobio?i...
Metallobio
When investing, capital is at risk. MetalloBio is an antimicrobials company, designing and testing completely new types of antibiotic drugs.
europe.republic.com
December 9, 2024 at 11:53 AM
Don't invest unless you're prepared to lose all the money you invest.
Our experienced Finance Director, and incredible research scientists' relentless work have ensured that we use funds cannily to conduct R&D. Invest today to see how much we can accomplish.
europe.republic.com/metallobio?i...
Our experienced Finance Director, and incredible research scientists' relentless work have ensured that we use funds cannily to conduct R&D. Invest today to see how much we can accomplish.
europe.republic.com/metallobio?i...
Don’t invest unless you’re prepared to lose all the money you invest.
What was good for Merck, is good for us. MetalloBio aims to provide solutions for patients and, all being well, profits shall follow. #AMR #HealthForAll
europe.republic.com/metallobio?i...
What was good for Merck, is good for us. MetalloBio aims to provide solutions for patients and, all being well, profits shall follow. #AMR #HealthForAll
europe.republic.com/metallobio?i...
December 6, 2024 at 5:04 PM
Don’t invest unless you’re prepared to lose all the money you invest.
What was good for Merck, is good for us. MetalloBio aims to provide solutions for patients and, all being well, profits shall follow. #AMR #HealthForAll
europe.republic.com/metallobio?i...
What was good for Merck, is good for us. MetalloBio aims to provide solutions for patients and, all being well, profits shall follow. #AMR #HealthForAll
europe.republic.com/metallobio?i...
Don't invest unless you're prepared to lose all the money you invest.
A message from our Executive Chairman and CEO Michael Murray post #GenesisLondon24 conference.
#AntimicrobialResistance #crowdfunding
europe.republic.com/metallobio/s...
A message from our Executive Chairman and CEO Michael Murray post #GenesisLondon24 conference.
#AntimicrobialResistance #crowdfunding
europe.republic.com/metallobio/s...
December 5, 2024 at 3:32 PM
Don't invest unless you're prepared to lose all the money you invest.
A message from our Executive Chairman and CEO Michael Murray post #GenesisLondon24 conference.
#AntimicrobialResistance #crowdfunding
europe.republic.com/metallobio/s...
A message from our Executive Chairman and CEO Michael Murray post #GenesisLondon24 conference.
#AntimicrobialResistance #crowdfunding
europe.republic.com/metallobio/s...
Don’t invest unless you’re willing to lose all the money you invest.
Our #R&D is directly funded by our investors, every pound counts. We have extended our first fundraising target, with the aim of conducting more antimicrobial testing. #crowdfunding #AMR
europe.republic.com/metallobio/s...
Our #R&D is directly funded by our investors, every pound counts. We have extended our first fundraising target, with the aim of conducting more antimicrobial testing. #crowdfunding #AMR
europe.republic.com/metallobio/s...
Metallobio
When investing, capital is at risk. MetalloBio is an antimicrobials company, designing and testing completely new types of antibiotic drugs.
europe.republic.com
December 4, 2024 at 3:40 PM
Don’t invest unless you’re willing to lose all the money you invest.
Our #R&D is directly funded by our investors, every pound counts. We have extended our first fundraising target, with the aim of conducting more antimicrobial testing. #crowdfunding #AMR
europe.republic.com/metallobio/s...
Our #R&D is directly funded by our investors, every pound counts. We have extended our first fundraising target, with the aim of conducting more antimicrobial testing. #crowdfunding #AMR
europe.republic.com/metallobio/s...
Don’t invest unless you’re prepared to lose all the money you invest.
We have entered an overfunding stage on our Seedrs campaign. Thank you! Those who haven't invested yet, there is now an additional 6 days to invest, each pound helps us fight against #AMR .
europe.republic.com/metallobio/s...
We have entered an overfunding stage on our Seedrs campaign. Thank you! Those who haven't invested yet, there is now an additional 6 days to invest, each pound helps us fight against #AMR .
europe.republic.com/metallobio/s...
Metallobio
When investing, capital is at risk. MetalloBio is an antimicrobials company, designing and testing completely new types of antibiotic drugs.
europe.republic.com
December 3, 2024 at 1:53 PM
Don’t invest unless you’re prepared to lose all the money you invest.
We have entered an overfunding stage on our Seedrs campaign. Thank you! Those who haven't invested yet, there is now an additional 6 days to invest, each pound helps us fight against #AMR .
europe.republic.com/metallobio/s...
We have entered an overfunding stage on our Seedrs campaign. Thank you! Those who haven't invested yet, there is now an additional 6 days to invest, each pound helps us fight against #AMR .
europe.republic.com/metallobio/s...
The MetalloBio crowdfunding campaign is only 3 days from closing. We have just over 325 investors now and hope that you might be one of those who joins this round before it closes. #AMR #Health
Don’t invest unless you’re prepared to lose all the money you invest.
europe.republic.com/metallobio/s...
Don’t invest unless you’re prepared to lose all the money you invest.
europe.republic.com/metallobio/s...
Metallobio
When investing, capital is at risk. MetalloBio is an antimicrobials company, designing and testing completely new types of antibiotic drugs.
europe.republic.com
December 2, 2024 at 5:38 PM
The MetalloBio crowdfunding campaign is only 3 days from closing. We have just over 325 investors now and hope that you might be one of those who joins this round before it closes. #AMR #Health
Don’t invest unless you’re prepared to lose all the money you invest.
europe.republic.com/metallobio/s...
Don’t invest unless you’re prepared to lose all the money you invest.
europe.republic.com/metallobio/s...
An insidious impact of #AMR is the burden it places on healthcare systems. Simple infections can become serious medical care issues. Our new medications would not only treat patients, but will free up precious/costly healthcare resources, and specialist medical and support staff. #invest #health
December 1, 2024 at 2:25 PM
Without effective antibiotics surgical
procedures and treatment of many diseases
will become almost impossible. What once were
treatable infections could become life
threatening. MetalloBio is working to
meet this global challenge through its
novel paradigm in antibiotics design. #AMR
#Worldhealth
procedures and treatment of many diseases
will become almost impossible. What once were
treatable infections could become life
threatening. MetalloBio is working to
meet this global challenge through its
novel paradigm in antibiotics design. #AMR
#Worldhealth
November 30, 2024 at 4:38 PM
Without effective antibiotics surgical
procedures and treatment of many diseases
will become almost impossible. What once were
treatable infections could become life
threatening. MetalloBio is working to
meet this global challenge through its
novel paradigm in antibiotics design. #AMR
#Worldhealth
procedures and treatment of many diseases
will become almost impossible. What once were
treatable infections could become life
threatening. MetalloBio is working to
meet this global challenge through its
novel paradigm in antibiotics design. #AMR
#Worldhealth
Current antibiotics are all closely related. This means that bacteria are able to quickly evolve resistance to them. MetalloBio compounds rapidly stop bacterial growth, preventing them from developing antibiotic resistance and treating the infection. #AMR #WorldHealth
November 28, 2024 at 1:03 PM
Current antibiotics are all closely related. This means that bacteria are able to quickly evolve resistance to them. MetalloBio compounds rapidly stop bacterial growth, preventing them from developing antibiotic resistance and treating the infection. #AMR #WorldHealth
MetalloBio Webinar- Friday 29 November 2024 at 15:00
Engage directly with Mike (CEO) and Jim (CSO) as they present MetalloBio’s business plan, route to investment return and the company’s science.
Contact edie.john@metallobio.com to reserve a place. Registration closes at 18:00 on Thursday, 28th.
Engage directly with Mike (CEO) and Jim (CSO) as they present MetalloBio’s business plan, route to investment return and the company’s science.
Contact edie.john@metallobio.com to reserve a place. Registration closes at 18:00 on Thursday, 28th.
November 27, 2024 at 12:56 PM
MetalloBio Webinar- Friday 29 November 2024 at 15:00
Engage directly with Mike (CEO) and Jim (CSO) as they present MetalloBio’s business plan, route to investment return and the company’s science.
Contact edie.john@metallobio.com to reserve a place. Registration closes at 18:00 on Thursday, 28th.
Engage directly with Mike (CEO) and Jim (CSO) as they present MetalloBio’s business plan, route to investment return and the company’s science.
Contact edie.john@metallobio.com to reserve a place. Registration closes at 18:00 on Thursday, 28th.
As #WAAW comes to a close MetalloBio wishes to focus on the end goal. Each one of our collaborator's
work brings us closer to potential new treatments that, based on our technology, could address untreatable
infections due to one of the biggest risks to global health, antimicrobial resistance. #AMR
work brings us closer to potential new treatments that, based on our technology, could address untreatable
infections due to one of the biggest risks to global health, antimicrobial resistance. #AMR
November 25, 2024 at 9:50 AM